Funds and ETFs Ajanta Pharma Limited

Equities

AJANTPHARM

INE031B01049

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:47 2024-05-03 am EDT 5-day change 1st Jan Change
2,384 INR +6.71% Intraday chart for Ajanta Pharma Limited +8.68% +14.41%

ETFs positioned on Ajanta Pharma Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.00% 117 M€ +2.11% -
0.00% 34 M€ +2.67% -
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
2,384 INR
Average target price
2,425 INR
Spread / Average Target
+1.71%
Consensus
  1. Stock Market
  2. Equities
  3. AJANTPHARM Stock
  4. Funds and ETFs Ajanta Pharma Limited